Department of Biomedical Informatics, Harvard Medical School, Boston Massachusetts.
JAMA Intern Med. 2017 Nov 1;177(11):1689-1690. doi: 10.1001/jamainternmed.2017.5017.
This study compares the utilization, cost, and outcome data from an insurance claims database to determine the difference in treatment efficacy between the branded and compounded versions of 17-alpha hydroxyprogesterone caproate.
本研究比较了保险索赔数据库中的利用、成本和结果数据,以确定 17-α-羟孕酮己酸酯的品牌药和复合药版本在治疗效果上的差异。